ZombieHealthcare
What Happened to Cero Therapeutics Holdings?
Ticker: CEROSPAC Year: 2021Merger: 2024
Return
-99.6%
Current Price
$0.04
Peak Price
$25600
Trust Size
$4M
Summary
CERo Therapeutics (now Cerevel Therapeutics Holdings) is a biotechnology company focused on developing engineered T-cell therapies for cancer using its proprietary CER-T platform.
What Happened
CERo Therapeutics went public through a SPAC merger and is developing cancer immunotherapies that use chimeric engulfment receptors rather than traditional CAR-T approaches. The stock has collapsed to pennies, and the company faces significant challenges in advancing its early-stage pipeline with limited financial resources.
Timeline
2021-09-28
S-1 Registration Filed
2024-01-22
Merger Proxy Filed (DEFM14A)
Risk Indicators
⚠️ Reverse Split